Canavan Disease [syndrom Canavanové]

topical
9
Terms

Bogaertův-Bertrandův syndrom
Canavanové syndrom dětský
Canavanové syndrom u dětí
deficit aminoacylázy 2
houbovitá degenerace bílé hmoty
leukodystrofie spongiformní
nedostatek aminoacylázy 2
nemoc Canavanové
nemoc Canavanové, familiární forma
nemoc Canavanové, familiární typ
nemoc Canavanové, juvenilní forma
nemoc Canavanové, juvenilní typ
nemoc Canavanové, novorozenecká forma
nemoc Canavanové, novorozenecký typ
nemoc Canavanové, sporadická forma
nemoc Canavanové, sporadický typ
spongiformní leukodystrofie
syndrom Canavanové, familiární forma
syndrom Canavanové, familiární typ
syndrom Canavanové, juvenilní forma
syndrom Canavanové, juvenilní typ
syndrom Canavanové, novorozenecká forma
syndrom Canavanové, novorozenecký typ
syndrom Canavanové, sporadická forma
syndrom Canavanové, sporadický typ

 

ACY2 Deficiency
Aminoacylase 2 Deficiency
ASP Deficiency
ASPA Deficiency
Aspartoacylase Deficiency
Canavan Disease, Familial Form
Canavan Disease, Infantile
Canavan Disease, Juvenile
Canavan Disease, Neonatal
Canavan Disease, Sporadic Form
Canavan Disease, Type I
Canavan Disease, Type II
Canavan Disease, Type III
Canavan-van Bogaert-Bertrand Disease
Deficiency Disease, Aspartoacylase
Familial Form of Canavan Disease
Infantile Canavan Disease
Juvenile Canavan Disease
Leukodystrophy, Spongiform
Neonatal Canavan Disease
Spongy Degeneration Of Central Nervous System
Spongy Degeneration of Infancy
Spongy Degeneration of the Brain
Spongy Degeneration of the Central Nervous System
Spongy Degeneration of White Matter In Infancy
Spongy Disease of Central Nervous System
Spongy Disease of White Matter
Sporadic Form of Canavan Disease
Type I Canavan Disease
Type II Canavan Disease
Type III Canavan Disease
Van Bogaert-Bertrand Syndrome
Von Bogaert-Bertrand Disease

Persistent link   https://www.medvik.cz/link/D017825
Definition

A rare neurodegenerative condition of infancy or childhood characterized by white matter vacuolization and demeylination that gives rise to a spongy appearance. Aspartoacylase deficiency leads to an accumulation of N-acetylaspartate in astrocytes. Inheritance may be autosomal recessive or the illness may occur sporadically. This illness occurs more frequently in individuals of Ashkenazic Jewish descent. The neonatal form features the onset of hypotonia and lethargy at birth, rapidly progressing to coma and death. The infantile form features developmental delay, DYSKINESIAS, hypotonia, spasticity, blindness, and megalencephaly. The juvenile form is characterized by ATAXIA; OPTIC ATROPHY; and DEMENTIA. (From Adams et al., Principles of Neurology, 6th ed, p944; Am J Med Genet 1988 Feb;29(2):463-71)

Annotation
do not confuse entry term CANAVAN-VAN BOGAERT-BERTRAND DISEASE with VAN BOGAERT'S LEUKOENCEPHALITIS see SUBACUTE SCLEROSING PANENCEPHALITIS
DUI
D017825 MeSH Browser
CUI
M0026932
Previous indexing
Cerebral Sclerosis, Diffuse (1981-1993); Demyelinating Diseases (1967-1993)
History note
94
Public note
94

C Diseases
C10.228.140 Brain Diseases 1 183
C10.228.140.163 Brain Diseases, Metabolic 85
C10.228.140.163.100.362.250 Adrenoleukodystrophy 43
C10.228.140.163.100.362.312 Alexander Disease 6
C10.228.140.163.100.362.375 Canavan Disease 9
C10.228.140.163.100.362.500 Leukodystrophy, Globoid Cell 17
C10.228.140.163.100.362.550 Leukodystrophy, Metachromatic 30
C10.228.140.163.100.362.775 Pelizaeus-Merzbacher Disease 11
C10.228.140.695 Leukoencephalopathies 12
C10.228.140.695.625.250 Adrenoleukodystrophy 43
C10.228.140.695.625.312 Alexander Disease 6
C10.228.140.695.625.375 Canavan Disease 9
C10.228.140.695.625.500 Leukodystrophy, Globoid Cell 17
C10.228.140.695.625.550 Leukodystrophy, Metachromatic 30
C10.228.140.695.625.775 Pelizaeus-Merzbacher Disease 11
C10.314.400.250 Adrenoleukodystrophy 43
C10.314.400.312 Alexander Disease 6
C10.314.400.375 Canavan Disease 9
C10.574.500.024 Alexander Disease 6
C10.574.500.300 Canavan Disease 9
C10.574.500.362 Cockayne Syndrome 4
C10.574.500.497 Huntington Disease 326
C10.574.500.529 Lafora Disease 1
C10.574.500.545 Myotonia Congenita 18
C10.574.500.547 Myotonic Dystrophy 96
C10.574.500.549 Neurofibromatoses 28
C10.574.500.850 Tourette Syndrome 86
C10.574.500.865 Tuberous Sclerosis 144
C16.320.400.024 Alexander Disease 6
C16.320.400.150 Canavan Disease 9
C16.320.400.200 Cockayne Syndrome 4
C16.320.400.430 Huntington Disease 326
C16.320.400.480 Lafora Disease 1
C16.320.400.540 Myotonia Congenita 18
C16.320.400.542 Myotonic Dystrophy 96
C16.320.400.550 Neuroacanthocytosis 6
C16.320.400.560 Neurofibromatoses 28
C16.320.400.820 Tourette Syndrome 86
C16.320.400.880 Tuberous Sclerosis 144
C16.320.565.189.362.250 Adrenoleukodystrophy 43
C16.320.565.189.362.312 Alexander Disease 6
C16.320.565.189.362.375 Canavan Disease 9
C16.320.565.189.362.500 Leukodystrophy, Globoid Cell 17
C16.320.565.189.362.550 Leukodystrophy, Metachromatic 30
C16.320.565.189.362.775 Pelizaeus-Merzbacher Disease 11
C18.452 Metabolic Diseases 1 200
C18.452.132.100.362.250 Adrenoleukodystrophy 43
C18.452.132.100.362.312 Alexander Disease 6
C18.452.132.100.362.375 Canavan Disease 9
C18.452.132.100.362.500 Leukodystrophy, Globoid Cell 17
C18.452.132.100.362.550 Leukodystrophy, Metachromatic 30
C18.452.132.100.362.775 Pelizaeus-Merzbacher Disease 11
C18.452.648.189.362.250 Adrenoleukodystrophy 43
C18.452.648.189.362.312 Alexander Disease 6
C18.452.648.189.362.375 Canavan Disease 9
C18.452.648.189.362.500 Leukodystrophy, Globoid Cell 17
C18.452.648.189.362.550 Leukodystrophy, Metachromatic 30
C18.452.648.189.362.775 Pelizaeus-Merzbacher Disease 11